(Q43913163)

English

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial

scientific article published in March 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with and without nelfinavir in children with HIV-1 who have not previously been treated: the PENTA 5 randomised trial (English)

1 reference

Europe PubMed Central

28 November 2017

1 reference

based on heuristic

inferred from title

author name string

Paediatric European Network for Treatment of AIDS (PENTA)

1

1 reference

Europe PubMed Central

28 November 2017

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

359

1 reference

Europe PubMed Central

28 November 2017

9308

1 reference

Europe PubMed Central

28 November 2017

733-740

1 reference

Europe PubMed Central

28 November 2017

British HIV Association guidelines for antiretroviral treatment of HIV Seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the International AIDS Society-USA panel

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Current evidence for the use of paediatric antiretroviral therapy--a PENTA analysis. Paediatric European Network for the Treatment of AIDS Steering Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of human immunodeficiency virus 1-infected infants and children with the protease inhibitor nelfinavir mesylate

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and single-dose pharmacokinetics of abacavir (1592U89) in human immunodeficiency virus type 1-infected children.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I study of abacavir (1592U89) alone and in combination with other antiretroviral agents in infants and children with human immunodeficiency virus infection. AIDS Clinical Trials Group 330 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Regression Analysis when the Dependent Variable Is Truncated Normal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Age-related reference ranges: significance tests for models and confidence intervals for centiles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cross sectional stature and weight reference curves for the UK, 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination Nucleoside Analog Reverse Transcriptase Inhibitor(s) Plus Nevirapine, Nelfinavir, or Ritonavir in Stable Antiretroviral Therapy-Experienced HIV-Infected Children: Week 24 Results of a Randomized Controlled Trial - PACTG 377

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of abacavir (ABC, 1592) in antiretroviral therapy-experienced patients: results from a randomized, double-blind, trial. CNA3002 European Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of and adherence to highly active antiretroviral therapy in children infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral effect and safety of abacavir alone and in combination with zidovudine in HIV-infected adults. Abacavir Phase 2 Clinical Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with human immunodeficiency virus type 1. Pediatric AIDS Clinical Trials Group 382 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2802%2907874-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(02)07874-1

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43913163&oldid=2104355536"